Intrinsiqs

Is Crinetics Pharmaceuticals, Inc. overvalued?

Crinetics Pharmaceuticals, Inc. (CRNX) — key valuation metrics and fundamentals.

No verdict
Price
$84.95
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$9.00B
Dividend yield
0.0%
Return on equity
-44.2%
Sector
Healthcare

See the full interactive analysis →

Fair value compares CRNX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.